Oncorus Announces Debt Capital Facility with K2 HealthVentures with $20 Million Funded at Closing, Relocation of Corporate Headquarters and Extension of Cash Runway
Previous
Previous
Ribon Therapeutics Secures $50 Million in Growth Capital from K2 HealthVentures
Next
Next